Key facts
- This page summarizes Tuan Tu Diep's Form 3/A - Amendment filing for Skye Bioscience, Inc. (SKYE).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 02 Apr 2026, 18:18.
Tuan Tu Diep - 04 Mar 2024 Form 3/A - Amendment Insider Report for Skye Bioscience, Inc. (SKYE)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- SKYE
- Reported as of
- 04 Mar 2024
- Net transaction value
- $0
- SEC form
- 3/A - Amendment
- Accepted by SEC
- 02 Apr 2026, 18:18:48 UTC
- Original report date
- 29 Feb 2024
- Prior SEC filing
- 04 Mar 2024
- Next SEC filing
- 30 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Punit S. Dhillon, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
Tuan Tu Diep filed Form 3/A - Amendment for Skye Bioscience, Inc. (SKYE) on 02 Apr 2026.
Change
- Previous filing in this sequence was filed on 04 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.
Reporting Owners (1)
CIK 0002013809
Primary reporting owner
Diep Tuan Tu
- Relationship
- Chief Operating Officer
- Address
- 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
- Signature
- /s/ Punit S. Dhillon, as Attorney-in-Fact
- Signature date
- 02 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SKYE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 72,833
- Date
- 04 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
SKYE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,000
- Date
- 04 Mar 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SKYE
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,000
- Exercise price
- $11.25
- Footnotes
- F3
SKYE
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,080
- Exercise price
- $14.50
- Footnotes
- F4
SKYE
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 22,021
- Exercise price
- $3.50
- Footnotes
- F5
SKYE
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,194
- Exercise price
- $3.50
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The restricted stock unit ("RSU") award was omitted from the Reporting Person's original Form 3, filed on March 4, 2024. Represents RSU awards for up to 72,833 shares that vest on the following performance milestones: 25% vests upon achieving a market cap of $125M, an additional 25% vests upon achieving a market cap of $250M, an additional 25% vests upon achieving a market cap of $400M, an additional 25% vest at an exit of $500M or greater; provided, however, that no RSUs shall vest until the compensation committee of the Issuer determines that shares can be sold into the market to cover withholding tax obligations associated with the vesting of the RSUs . Upon a change in control of the Issuer, 100% of the RSUs will become fully vested.
Footnote F2
The restricted stock unit ("RSU") award was omitted from the Reporting Person's original Form 3, filed on March 4, 2024. Represents a RSU award that vests in three equal annual installments commencing on the first anniversary of the grant date, December 14, 2021 Upon a change in control of the Issuer, all of the RSUs will vest in full.
Footnote F3
The stock option was omitted from the Reporting Person's original Form 3, filed on March 4, 2024. The stock option vests 10% on the grant date, October 5, 2020, and the remaining 90% of the stock option will vest in equal semi-annual installments over four annual periods. Upon a change in control of the Issuer, 100% of the stock option will become fully vested.
Footnote F4
The stock option was omitted from the Reporting Person's original Form 3, filed on March 4, 2024. The stock option vests 25% on the one year anniversary of the grant date, December 14, 2021, and 1/48th monthly thereafter. Upon a change in control of the Issuer, 100% of the stock option will become fully vested.
Footnote F5
The stock option was omitted from the Reporting Person's original Form 3, filed on March 4, 2024. The stock option vests in equal monthly installments over the four year period beginning August 24, 2023. The grant date for the stock option is August 25, 2023. Upon a change in control of the Issuer, 100% of the stock option will become fully vested.
Footnote F6
The stock option was omitted from the Reporting Person's original Form 3, filed on March 4, 2024. The stock option vests in equal monthly installments over the four year period beginning August 24, 2023. The grant date for the stock option is November 6, 2023. Upon a change in control of the Issuer, 100% of the stock option will become fully vested.